Passage Bio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
PASG Nasdaq 8731 https://www.passagebio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Passage Bio Inc

Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - Apr 22nd, 2024 11:00 am
Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should Know - Mar 7th, 2024 5:00 pm
Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program - Mar 5th, 2024 12:00 pm
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights - Mar 4th, 2024 12:00 pm
Passage Bio to Participate in Upcoming Investor Conferences - Feb 27th, 2024 12:00 pm
We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully - Feb 12th, 2024 2:14 pm
7 Analyst-Backed Stocks With Promising 10-Bagger Potential - Feb 2nd, 2024 12:09 am
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - Jan 31st, 2024 12:30 pm
7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight - Dec 26th, 2023 3:14 am
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities - Dec 20th, 2023 12:00 pm
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - Nov 17th, 2023 9:30 pm
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights - Nov 13th, 2023 12:00 pm
Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference - Oct 30th, 2023 11:00 am
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 20th, 2023 8:30 pm
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference - Sep 25th, 2023 11:00 am
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans? - Sep 5th, 2023 1:31 pm
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights - Aug 7th, 2023 11:15 am
Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study - Aug 7th, 2023 11:00 am
Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors - Jul 31st, 2023 11:00 am
12 Best Nano Cap Stocks To Buy Now - Jul 6th, 2023 3:17 pm